|
|
|
|
|
2009/05/08
MRSA Skin Infections and Rapid Testing in the ED
|
Course Objectives
|
|
|
After this activity, the participant should be able to:
• Describe the history of MRSA.
• Recognize the emergence of MRSA as a common cause of community-acquired skin infections.
• Apply appropriate empiric therapy for skin infections that may involve MRSA.
• Summarize how rapid testing could influence treatment of skin infections and isolation decisions.
• Propose to patients methods to prevent MRSA infection.
|
|
|
|
top
|
|
|
To Receive A Certificate
|
|
|
|
Review the material in the Course Presentations section.
|
|
|
|
Complete the CME Posttest with a score of 14 out of 19 questions correct.
|
|
|
|
You will then be asked to register and complete a brief course evaluation.
|
|
|
|
A certificate will be automatically generated for you online.
|
|
|
|
|
|
|
|
Target Audience
|
|
|
|
This activity is intended for Healthcare Providers, in particular those with a focus on Emergency Medicine and Infectious Disease.
|
|
|
|
top
|
|
|
|
|
Method of Participation
|
|
|
To receive continuing education credit, the learner must:
1. Participate in the live webcast in its entirety (Registration available at www.emcme.com); and
2. Complete the online post-test and evaluation.
|
|
|
|
top
|
|
|
|
|
|
|
Accreditation
|
|
|
The University of Nebraska Medical Center, Center for Continuing Education is accredited by the ACCME to provide continuing medical education for physicians.
The University of Nebraska Medical Center, Center for Continuing Education designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of The University of Nebraska Medical Center, Center for Continuing Education and The Institute for Health Protection.
|
|
|
|
top
|
|
|
|
|
Faculty
|
|
|
Gregory J. Moran, MD, FACEP, FAAEM, FIDSA
Professor of Medicine
UCLA School of Medicine Dept. of Emergency Medicine and Division of Infectious Diseases Olive View - UCLA Medical Center
Dr. Moran is the lead author of the seminal New England Journal of Medicine article on the emergence of MRSA among Emergency Department patients with skin and soft tissue infections.
|
|
|
|
top
|
|
|
|
|
Disclosure
|
|
|
The faculty and planning committee have been advised that this activity must be free from commercial bias and based upon all the available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis. This presenter has indicated, in accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards that he has a relationship which, in the context of their presentation, could be perceived by some as a real or apparent conflict of interest (e.g., ownership of stock, grants, honoraria, or consulting fees), but these presenters do not consider that it will influence their presentation.
Research Funding: Johnson & Johnson, Pfizer, Rib-X Pharmaceuticals
Speaking Honoraria: Pfizer, Cubist, Schering-Plough, Merck, Ortho-McNeil
Consulting: Cepheid, ProGen Tech
|
|
|
|
top
|
|
|
|
|
Support
|
|
|
|
Supported by an educational grant from Cepheid.
|
|
|
|
top
|
|
|
|
|
Sponsorship
|
|
|
|
This activity is jointly sponsored by the UNMC Center for Continuing Education and the Institute for Health Protection (IHP).
|
|
|
|
top
|
|
|
|
|
|
|
